UPDATE 1-Glaxo, Theravance Breo lung drug fails to extend life in huge study
September 08, 2015 at 15:53 PM EDT
Sept 8 (Reuters) - GlaxoSmithKline Plc and its partner Theravance Inc on Tuesday said their inhaled medicine Breo failed to prolong life of patients with chronic respiratory disease in a huge, high-stakes clinical trial.
